Key result
Among ESRD patients undergoing chronic hemodialysis, the prevalence of pericardial effusion was 12.9%, which was significantly associated with elevated serum BUN, creatinine, calcium, and phosphorus levels.
Why the study?
Pericardial effusion and pericarditis cause 3-5% of deaths from tamponade, fatal arrhythmia, and heart failure, prompting evaluation of pericardial effusion prevalence and predisposing factors in ESRD patients undergoing dialysis.
What is the prevalence of pericardial effusion among ESRD patients undergoing chronic hemodialysis?
Cross-Sectional (n=132)
Yes
What is the prevalence of pericardial effusion among ESRD patients undergoing chronic hemodialysis?
Pericardial effusion is present in a notable proportion of ESRD patients on chronic hemodialysis, suggesting echocardiography may be a useful tool to assess dialysis effectiveness.
Links pericardial effusion to uremic markers in hemodialysis; leaves open echocardiography's role in guiding care.
Objective: Pericardial effusion and pericarditis are responsible for 3–5% of deaths due to tamponade, fatal arrhythmia and heart failure. Improvement in dialysis methods has allowed the initiation of the treatment at early stages. This study is designed to evaluate the prevalence of pericardial effusion and its predisposing factors among end-stage renal disease (ESRD) patients undergoing dialysis. Methods: This is a cross-sectional study that included patients from the two Medical Centers in (XXX). These patients were presented with ESRD with a GFR <10 cc/min and were under long-term dialysis, also called chronic hemodialysis. The echocardiography was performed and patients with pericarditis and/or pericardial effusion due to non-uremic causes or dialysis were excluded. Results: Of 132 patients included, mild pericardial effusion was observed in 17(12.9%) patients, 8(6.1%) patients were presented with moderate and 1 (0.7%) had severe pericardial effusion. Among females, 9(15.8%) showed pericardial effusion whereas, it was reported in 8(10.7%) males, with no statistically significant difference. Furthermore, no significant difference was seen in the ages or etiologies of patients with or without pericardial effusion (50.5 ± 15.5 vs 52.8 ± 16.1, respectively). Conclusion: Our study reports that echocardiography among dialysis patients is likely to determine the effectiveness of the dialysis procedure and can be a cost-effective approach. Futher studies regarding laboratory parameters are required in this area. HIGHLIGHTS Improvement in dialysis methods has allowed the initiation of the treatment at early stages. Echocardiography among dialysis patients is likely to determine the effectiveness of the dialysis procedure. Furthermore, normal serum BUN and Cr concentrations are not reliable predictors of effective dialysis alone. Normal serum BUN and Cr concentrations are not solely reliable predictors of effective hemodialysis.
No takes yet. Share an insight, caveat, or question.
Aghsaeifard et al. (2022) conducted a cross-sectional in End-Stage Renal Disease (ESRD) (n=132). End-stage renal disease on chronic hemodialysis was evaluated on Prevalence of pericardial effusion. Among ESRD patients undergoing chronic hemodialysis, the prevalence of pericardial effusion was 12.9%, which was significantly associated with elevated serum BUN, creatinine, calcium, and phosphorus levels.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: